LRP1 communicates with proteins implicated in the synthesis of Aβ, such as APP, beta-site amyloid precursor protein cleaving enzyme 1 (BACE1), and presenilin (PS), and its expression is reduced at the blood-brain barrier in AD patients. Here, APP is linked to Alzheimer disease.